Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLAD of spinal chloroprocaine for inguinal hernia repair in ambulatory surgery
2014-005469-58Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of chloroprocaine in inguinal hernia, sponsored by Ghent University Hospital. Primary endpoint: Minimum local anesthetic dose (MLAD) of chloroprocaine 1% with sufentanil. Started Dec 2014; status: completed.
02
Drugs
chloroprocaine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on 2014-005469-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005469-58.